Goldklang, Monica P.
Tekabe, Yared
Zelonina, Tina
Trischler, Jordis
Xiao, Rui
Stearns, Kyle
Rodriguez, Krissy
Shields, Alexander
Romanov, Alexander
D’Armiento, Jeanine M. http://orcid.org/0000-0002-6219-6083
Johnson, Lynne L.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01 HL116346, R01 HL086936, T32 HL007343, K08 HL126071)
National Institute of Neurological Disorders and Stroke (R25 NS076445)
National Center for Advancing Translational Sciences (U01 TR000040)
Article History
Received: 16 October 2018
Accepted: 30 April 2019
First Online: 10 June 2019
Ethics approval
: All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee of Columbia University.
: Not applicable
: Patent PCT/US2008/012374, Antibody to RAGE and uses for in vivo Imaging or for Targeting Therapy, was awarded to LLJ and YT and was licensed to Columbia University. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.